Byrne Asset Management’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5K | Buy |
5,000
+2,000
| +67% | +$4.18K | 0.01% | 397 |
|
|
2025
Q1 | $5.13K | Hold |
3,000
| – | – | ﹤0.01% | 466 |
|
|
2024
Q4 | $15.2K | Hold |
3,000
| – | – | 0.01% | 334 |
|
|
2024
Q3 | $16.3K | Hold |
3,000
| – | – | 0.01% | 331 |
|
|
2024
Q2 | $14.1K | Hold |
3,000
| – | – | 0.01% | 330 |
|
|
2024
Q1 | $9.33K | Buy |
3,000
+1,000
| +50% | +$3.11K | 0.01% | 377 |
|
|
2023
Q4 | $5.96K | Hold |
2,000
| – | – | ﹤0.01% | 400 |
|
|
2023
Q3 | $6K | Buy |
+2,000
| New | +$6K | 0.01% | 381 |
|